Cargando…

Impact of the Xinsorb Scaffold-Related Parameters on Platelet Reactivity in Patients with Single De Novo Coronary Artery Lesions Undergoing Clopidogrel Treatment

BACKGROUND: This study aimed to assess the relationship between stent parameters and platelet function, as well as the platelet reactivity profiles over time in patients treated with the Xinsorb scaffold. METHODS: Adenosine diphosphate-induced maximal amplitude was measured as clopidogrel on-treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Shushu, Wang, Mingliang, Yan, Meiyu, Wang, Bo, Xu, Yawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Turkish Society of Cardiology 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339140/ https://www.ncbi.nlm.nih.gov/pubmed/37288850 http://dx.doi.org/10.14744/AnatolJCardiol.2023.3071

Ejemplares similares

First-in-man Implantation of the XINSORB Bioresorbable Sirolimus-eluting Scaffold in China
por: Chen, Jia-Hui, et al.
Publicado: (2015)

Final report of the 5-year clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in the treatment of single de novo coronary lesions in a first-in-human study
por: Wu, Yizhe, et al.
Publicado: (2020)

The first six-month clinical outcomes and risk factors associated with high on-treatment platelet reactivity of clopidogrel in patients undergoing coronary interventions
por: Tekkeşin, Ahmet İlker, et al.
Publicado: (2016)

Impact of renal function on residual platelet reactivity and clinical outcomes in patients with acute coronary syndrome treated with clopidogrel
por: Li, Qing, et al.
Publicado: (2021)

Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis
por: Wu, Yizhe, et al.
Publicado: (2020)

Genotyping of six clopidogrel-metabolizing enzyme polymorphisms has a minor role in the assessment of platelet reactivity in patients with acute coronary syndrome
por: García-Lagunar, María Henar, et al.
Publicado: (2017)

Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus
por: Zhang, Dingyu, et al.
Publicado: (2016)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
por: Kuliczkowski, Wiktor, et al.
Publicado: (2021)

Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity
por: Kille, Alexander, et al.
Publicado: (2021)

High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel
por: Geisler, Tobias, et al.
Publicado: (2015)

Temporal Variability of Platelet Reactivity in Patients Treated with Clopidogrel or Ticagrelor
por: Yun, Kyeong Ho, et al.
Publicado: (2019)

The standard versus prolonged dual antiplatelet therapy after the XINSORB bioresorbable scaffold implantation (SPARTA) trial: study protocol for a randomized controlled trial
por: Wu, Yizhe, et al.
Publicado: (2023)

Impact of On-Clopidogrel Platelet Reactivity on Incidence of Peri-Interventional Bleeding in Patients Undergoing Transcatheter Aortic Valve Implantation
por: Kille, Alexander, et al.
Publicado: (2022)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study
por: Schuette, Claudia, et al.
Publicado: (2015)

Effects of Ramadan fasting on platelet reactivity in diabetic patients treated with clopidogrel
por: Bouida, W., et al.
Publicado: (2017)

Platelet reactivity after clopidogrel loading in patients with acute ischemic stroke
por: Enomoto, Yukiko, et al.
Publicado: (2022)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Comparison of prasugrel and clopidogrel reloading on high platelet reactivity in clopidogrel-loaded patients undergoing percutaneous coronary intervention (PRAISE-HPR): a study protocol for a prospective randomized controlled clinical trial
por: Lee, Dong-Hyun, et al.
Publicado: (2013)

Decreased platelet responsiveness to clopidogrel correlates with CYP2C19 and PON1 polymorphisms in atherosclerotic patients
por: Marchini, J.F.M., et al.
Publicado: (2017)

Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
por: Yao, Yi, et al.
Publicado: (2016)

Comparison of Acute Recoil between Bioabsorbable Poly-L-lactic Acid XINSORB Stent and Metallic Stent in Porcine Model
por: Wu, Yizhe, et al.
Publicado: (2012)

Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects
por: Dobesh, Paul P, et al.
Publicado: (2015)

Worse survival of invasive melanoma patients in men and “de novo” lesions()()
por: Giavina-Bianchi, Mara Huffenbaecher, et al.
Publicado: (2020)

The Impact of Smoking on Post-Clopidogrel Platelet Reactivity in Patients With Acute Myocardial Infarction
por: Cho, Jung-Hyun, et al.
Publicado: (2010)

Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy
por: Kim, Sehun, et al.
Publicado: (2021)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Clopidogrel versus ticagrelor in the treatment of Chinese patients undergoing percutaneous coronary intervention: effects on platelet function assessed by platelet function tests and mean platelet volume
por: Zhang, Yang, et al.
Publicado: (2021)

Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium
por: Verma, Shefali Setia, et al.
Publicado: (2020)

Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study
por: Takahashi, Yasuo, et al.
Publicado: (2013)

Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome
por: Efe, Edem, et al.
Publicado: (2016)

A Combination of Aspirin and Clopidogrel Predict More Favorable Dynamics of Platelet Reactivity versus Clopidogrel Alone in the Acute Phase of Minor Stroke
por: Wiśniewski, Adam, et al.
Publicado: (2021)

Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
por: Habibi, Zarina, et al.
Publicado: (2023)

Unfavorable Changes of Platelet Reactivity on Clopidogrel Therapy Assessed by Impedance Aggregometry Affect a Larger Volume of Acute Ischemic Lesions in Stroke
por: Wiśniewski, Adam, et al.
Publicado: (2021)

Impact of Aspirin and Clopidogrel Interruption on Platelet Function in Patients Undergoing Major Vascular Surgery
por: Le Manach, Yannick, et al.
Publicado: (2014)

Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
por: Zhuo, Zhong-ling, et al.
Publicado: (2018)

Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial
por: Schnorbus, Boris, et al.
Publicado: (2021)

Comparison of Triple Anti-Platelet Therapy (Aspirin, Clopidogrel, and Cilostazol) and Double Anti-Platelet Therapy (Aspirin and Clopidogrel) on Platelet Aggregation in Type 2 Diabetic Patients Undergoing Drug-Eluting Stent Implantation
por: Yang, Tae-Hyun, et al.
Publicado: (2009)

Genetic determinants of platelet response to clopidogrel
por: Kubica, Aldona, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_mv4f1ju3oeuicrelsom14se1dj